The future of sustained business growth belongs to the organizations that recognize that the product is the most powerful ...
Stryker (SYK) delivered strong Q3 2025 results, raising full-year guidance on robust organic growth across both MedSurg & Neurotechnology and Orthopaedics segments. SYK achieved double-digit organic ...
Boston Scientific continues to deliver robust growth, but valuation limits upside despite strong execution and leading positions in key medical device markets. BSX's growth drivers—Farapulse (PFA), ...
The debate between growth and value investing is as old as equity markets themselves. Investors across geographies and cycles have tried to answer the same question: is it better to pay up for ...